April 10, 2026 03:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Israel says Hezbollah chief’s nephew-cum-secretary killed in Beirut strikes last night | Modi slams TMC on trade, fisheries at Haldia; vows 7th pay commission for govt employees | ‘US military will remain in and around Iran’: Trump amid fragile ceasefire | BJP eyes Assam hattrick, Puducherry comeback; LDF faces Kerala test | Israel claims Hezbollah chief's nephew killed in Beirut strikes last night | Jaishankar’s high-stakes diplomatic tour: EAM to visit UAE this week, first visit amid Middle East conflict | Passport row: Barricades outside Pawan Khera’s Hyderabad house after Himanta Biswa Sarma's warning | ‘Allow excluded voters to vote’: Mamata slams voter list freeze amid SIR row, to move Supreme Court | US, Iran agree to 2-week ceasefire deal, reopening Strait of Hormuz | ‘Prudent to wait and watch’: RBI keeps repo rate unchanged at 5.25% amid global volatility

'Make in India' initiative partners with BioAsia 2016

| | Jan 20, 2016, at 12:44 am
New Delhi, Jan 19 (IBNS) BioAsia, Asia's biggest technology and bio-business platform, has on Tuesday announced that the Make in India initiative by Government of India has partnered with the 13th edition of BioAsia to be held in Hyderabad from Feb 8 to Feb 10.

The partnership will make BioAsia the only BioPharma event to associate with this ambitious initiative of the Government of India. ‘Make in India’ partnership will also enhance the level of the impact of the deliberations at the event, given that the relevant policy makers will be attendance at the event, to interact and engage with the industry and academic stakeholder.

India is among the countries considered as likely to have the strongest gains in developing next generation life-saving products in the coming decade. Recognizing this opportunity and rightly so, Government of India through its ‘Make in India’ initiative has attached ample emphasis on the pharmaceuticals and biotechnology sectors to fortify the country manufacturing ecosystem, to enhance development of skills, nurture a conducive regulatory environment, foster innovation and protect intellectual property.

The initiative aims to encourage not only global companies to invest in India, but also enliven domestic players to increase their size. Complementing the Make in India initiative is the Telangana Government’s first-of-its-kind Pharma City, spread across 15,000 acres and at par with international standards.

Under this context, CEO Conclave of this edition of BioAsia will focus on “Make in India - Flavors of policy change”.

The conclave will elicit thought provoking discussions on the opportunities and challenges for the sector under the Make in India program, besides proposing various policy measures that can accelerate the growth of life sciences sector in India.

Shakthi Nagappan, CEO – BioAsia, while commenting on the partnership with Make in India, said, “Make in India’s partnership with BioAsia is a testimony to the value that BioAsia has created for the life sciences industry over the last 12 years. We are sure that focused sessions around Make in India at BioAsia 2016 will add immense value to the all participants especially the pharma and biotech manufacturers”
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm